SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-010309
Filing Date
2020-08-11
Accepted
2020-08-11 15:37:51
Documents
63
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nrbo-20200630x10q.htm 10-Q 1135991
2 EX-10.2 nrbo-20200630ex102564787.htm EX-10.2 188655
3 EX-31.1 nrbo-20200630ex31187f5f2.htm EX-31.1 17126
4 EX-32.1 nrbo-20200630ex3217e2e1b.htm EX-32.1 10950
  Complete submission text file 0001558370-20-010309.txt   5104803

Data Files

Seq Description Document Type Size
5 EX-101.INS nrbo-20200630.xml EX-101.INS 926454
6 EX-101.SCH nrbo-20200630.xsd EX-101.SCH 44753
7 EX-101.CAL nrbo-20200630_cal.xml EX-101.CAL 41956
8 EX-101.DEF nrbo-20200630_def.xml EX-101.DEF 163717
9 EX-101.LAB nrbo-20200630_lab.xml EX-101.LAB 403706
10 EX-101.PRE nrbo-20200630_pre.xml EX-101.PRE 300518
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37809 | Film No.: 201092267
SIC: 2834 Pharmaceutical Preparations